The global Congestive Heart Failure (CHF) Treatment Devices market size is expected to reach US$ 6369.4 million by 2029, growing at a CAGR of 3.1% from 2023 to 2029.

Congestive Heart Failure (CHF) Treatment Devices - Market

Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).

The market is mainly driven by the significant applications of Congestive Heart Failure (CHF) Treatment Devices in various end use industries. The expanding demands from the Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD) and Biventricular Assist Device (BIVAD),, are propelling Congestive Heart Failure (CHF) Treatment Devices market. Cardiac Resynchronization Therapy (CRT), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Implantable Cardioverter Defibrillators (ICDs) segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Congestive Heart Failure (CHF) Treatment Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Congestive Heart Failure (CHF) Treatment Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Congestive Heart Failure (CHF) Treatment Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Congestive Heart Failure (CHF) Treatment Devices sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Congestive Heart Failure (CHF) Treatment Devices covered in this report include Abiomed, Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International, Jarvik Heart, LivaNova PLC, Medtronic and ReliantHeart, etc.

The global Congestive Heart Failure (CHF) Treatment Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Abiomed

Berlin Heart GmbH

Biotronik SE & Co. KG

Boston Scientific Corporation

HeartWare International

Jarvik Heart

LivaNova PLC

Medtronic

ReliantHeart

Abbott

Scope of Congestive Heart Failure (CHF) Treatment Devices - Market Report

Report Metric	Details
Report Name	Congestive Heart Failure (CHF) Treatment Devices - Market
Forecasted market size in 2029	US$ 6369.4 million
CAGR	3.1%
Forecasted years	2023 - 2029
Global Congestive Heart Failure (CHF) Treatment Devices market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.) Global Congestive Heart Failure (CHF) Treatment Devices market, Segment by Type: Cardiac Resynchronization Therapy (CRT) Implantable Cardioverter Defibrillators (ICDs)
Global Congestive Heart Failure (CHF) Treatment Devices market, by Application	Left Ventricular Assist Device (LVAD) Right Ventricular Assist Device (RVAD) Biventricular Assist Device (BIVAD)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Congestive Heart Failure (CHF) Treatment Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Congestive Heart Failure (CHF) Treatment Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Congestive Heart Failure (CHF) Treatment Devices - Market size in 2029?

Ans: The Congestive Heart Failure (CHF) Treatment Devices - Market size in 2029 will be US$ 6369.4 million.

What are the Application segmentation covered in the Congestive Heart Failure (CHF) Treatment Devices - Market report?

Ans: The Applications covered in the Congestive Heart Failure (CHF) Treatment Devices - Market report are Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)

1 Congestive Heart Failure (CHF) Treatment Devices Market Overview

1.1 Congestive Heart Failure (CHF) Treatment Devices Product Overview

1.2 Congestive Heart Failure (CHF) Treatment Devices Market Segment by Type

1.2.1 Cardiac Resynchronization Therapy (CRT)

1.2.2 Implantable Cardioverter Defibrillators (ICDs)

1.3 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Type

1.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Overview by Type (2018-2029)

1.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Historic Market Size Review by Type (2018-2023)

1.3.3 Global Congestive Heart Failure (CHF) Treatment Devices Forecasted Market Size by Type (2024-2029)

1.4 Key Regions Market Size Segment by Type

1.4.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Type (2018-2023)

1.4.2 Europe Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Type (2018-2023)

1.4.3 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Type (2018-2023)

1.4.4 Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Type (2018-2023)

1.4.5 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Type (2018-2023)

2 Global Congestive Heart Failure (CHF) Treatment Devices Market Competition by Company

2.1 Global Top Players by Congestive Heart Failure (CHF) Treatment Devices Sales (2018-2023)

2.2 Global Top Players by Congestive Heart Failure (CHF) Treatment Devices Revenue (2018-2023)

2.3 Global Top Players by Congestive Heart Failure (CHF) Treatment Devices Price (2018-2023)

2.4 Global Top Manufacturers Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base Distribution, Sales Area, Product Type

2.5 Congestive Heart Failure (CHF) Treatment Devices Market Competitive Situation and Trends

2.5.1 Congestive Heart Failure (CHF) Treatment Devices Market Concentration Rate (2018-2023)

2.5.2 Global 5 and 10 Largest Manufacturers by Congestive Heart Failure (CHF) Treatment Devices Sales and Revenue in 2022

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Congestive Heart Failure (CHF) Treatment Devices as of 2022)

2.7 Date of Key Manufacturers Enter into Congestive Heart Failure (CHF) Treatment Devices Market

2.8 Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Offered

2.9 Mergers & Acquisitions, Expansion

3 Congestive Heart Failure (CHF) Treatment Devices Status and Outlook by Region

3.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029

3.2 Global Congestive Heart Failure (CHF) Treatment Devices Historic Market Size by Region

3.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Region (2018-2023)

3.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales in Value by Region (2018-2023)

3.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)

3.3 Global Congestive Heart Failure (CHF) Treatment Devices Forecasted Market Size by Region

3.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Region (2024-2029)

3.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales in Value by Region (2024-2029)

3.3.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Congestive Heart Failure (CHF) Treatment Devices by Application

4.1 Congestive Heart Failure (CHF) Treatment Devices Market Segment by Application

4.1.1 Left Ventricular Assist Device (LVAD)

4.1.2 Right Ventricular Assist Device (RVAD)

4.1.3 Biventricular Assist Device (BIVAD)

4.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Application

4.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Overview by Application (2018-2029)

4.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Historic Market Size Review by Application (2018-2023)

4.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Forecasted Market Size by Application (2024-2029)

4.3 Key Regions Market Size Segment by Application

4.3.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Application (2018-2023)

4.3.2 Europe Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Application (2018-2023)

4.3.3 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Application (2018-2023)

4.3.4 Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Application (2018-2023)

4.3.5 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Application (2018-2023)

5 North America Congestive Heart Failure (CHF) Treatment Devices by Country

5.1 North America Congestive Heart Failure (CHF) Treatment Devices Historic Market Size by Country

5.1.1 North America Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

5.1.2 North America Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Country (2018-2023)

5.1.3 North America Congestive Heart Failure (CHF) Treatment Devices Sales in Value by Country (2018-2023)

5.2 North America Congestive Heart Failure (CHF) Treatment Devices Forecasted Market Size by Country

5.2.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Country (2024-2029)

5.2.2 North America Congestive Heart Failure (CHF) Treatment Devices Sales in Value by Country (2024-2029)

6 Europe Congestive Heart Failure (CHF) Treatment Devices by Country

6.1 Europe Congestive Heart Failure (CHF) Treatment Devices Historic Market Size by Country

6.1.1 Europe Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

6.1.2 Europe Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Country (2018-2023)

6.1.3 Europe Congestive Heart Failure (CHF) Treatment Devices Sales in Value by Country (2018-2023)

6.2 Europe Congestive Heart Failure (CHF) Treatment Devices Forecasted Market Size by Country

6.2.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Country (2024-2029)

6.2.2 Europe Congestive Heart Failure (CHF) Treatment Devices Sales in Value by Country (2024-2029)

7 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices by Region

7.1 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Historic Market Size by Region

7.1.1 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029

7.1.2 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Region (2018-2023)

7.1.3 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales in Value by Region (2018-2023)

7.2 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Forecasted Market Size by Region

7.2.1 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Region (2024-2029)

7.2.2 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales in Value by Region (2024-2029)

8 Latin America Congestive Heart Failure (CHF) Treatment Devices by Country

8.1 Latin America Congestive Heart Failure (CHF) Treatment Devices Historic Market Size by Country

8.1.1 Latin America Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

8.1.2 Latin America Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Country (2018-2023)

8.1.3 Latin America Congestive Heart Failure (CHF) Treatment Devices Sales in Value by Country (2018-2023)

8.2 Latin America Congestive Heart Failure (CHF) Treatment Devices Forecasted Market Size by Country

8.2.1 Latin America Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Country (2024-2029)

8.2.2 Latin America Congestive Heart Failure (CHF) Treatment Devices Sales in Value by Country (2024-2029)

9 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices by Country

9.1 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Historic Market Size by Country

9.1.1 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

9.1.2 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Country (2018-2023)

9.1.3 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales in Value by Country (2018-2023)

9.2 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Forecasted Market Size by Country

9.2.1 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Country (2024-2029)

9.2.2 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales in Value by Country (2024-2029)

10 Company Profiles

10.1 Abiomed

10.1.1 Abiomed Company Information

10.1.2 Abiomed Introduction and Business Overview

10.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Products Offered

10.1.5 Abiomed Recent Development

10.2 Berlin Heart GmbH

10.2.1 Berlin Heart GmbH Company Information

10.2.2 Berlin Heart GmbH Introduction and Business Overview

10.2.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Products Offered

10.2.5 Berlin Heart GmbH Recent Development

10.3 Biotronik SE & Co. KG

10.3.1 Biotronik SE & Co. KG Company Information

10.3.2 Biotronik SE & Co. KG Introduction and Business Overview

10.3.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Products Offered

10.3.5 Biotronik SE & Co. KG Recent Development

10.4 Boston Scientific Corporation

10.4.1 Boston Scientific Corporation Company Information

10.4.2 Boston Scientific Corporation Introduction and Business Overview

10.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Products Offered

10.4.5 Boston Scientific Corporation Recent Development

10.5 HeartWare International

10.5.1 HeartWare International Company Information

10.5.2 HeartWare International Introduction and Business Overview

10.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2018-2023)

10.5.4 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Products Offered

10.5.5 HeartWare International Recent Development

10.6 Jarvik Heart

10.6.1 Jarvik Heart Company Information

10.6.2 Jarvik Heart Introduction and Business Overview

10.6.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Products Offered

10.6.5 Jarvik Heart Recent Development

10.7 LivaNova PLC

10.7.1 LivaNova PLC Company Information

10.7.2 LivaNova PLC Introduction and Business Overview

10.7.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2018-2023)

10.7.4 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Products Offered

10.7.5 LivaNova PLC Recent Development

10.8 Medtronic

10.8.1 Medtronic Company Information

10.8.2 Medtronic Introduction and Business Overview

10.8.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Medtronic Congestive Heart Failure (CHF) Treatment Devices Products Offered

10.8.5 Medtronic Recent Development

10.9 ReliantHeart

10.9.1 ReliantHeart Company Information

10.9.2 ReliantHeart Introduction and Business Overview

10.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2018-2023)

10.9.4 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Products Offered

10.9.5 ReliantHeart Recent Development

10.10 Abbott

10.10.1 Abbott Company Information

10.10.2 Abbott Introduction and Business Overview

10.10.3 Abbott Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2018-2023)

10.10.4 Abbott Congestive Heart Failure (CHF) Treatment Devices Products Offered

10.10.5 Abbott Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Congestive Heart Failure (CHF) Treatment Devices Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Congestive Heart Failure (CHF) Treatment Devices Industrial Chain Analysis

11.4 Congestive Heart Failure (CHF) Treatment Devices Market Dynamics

11.4.1 Congestive Heart Failure (CHF) Treatment Devices Industry Trends

11.4.2 Congestive Heart Failure (CHF) Treatment Devices Market Drivers

11.4.3 Congestive Heart Failure (CHF) Treatment Devices Market Challenges

11.4.4 Congestive Heart Failure (CHF) Treatment Devices Market Restraints

12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Congestive Heart Failure (CHF) Treatment Devices Distributors

12.3 Congestive Heart Failure (CHF) Treatment Devices Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Abiomed Inc

Berlin Heart GmbH

BIOTRONIK SE & Co. KG

Boston Scientific Corporation

Heartware International

List of Tables

Table 1. Major Company of Cardiac Resynchronization Therapy (CRT)

Table 2. Major Company of Implantable Cardioverter Defibrillators (ICDs)

Table 3. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type 2018 VS 2022 VS 2029 (US$ Million)

Table 4. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (K Units)

Table 5. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Type (2018-2023)

Table 6. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (US& Million)

Table 7. Global Congestive Heart Failure (CHF) Treatment Devices Market Share in Value by Type (2018-2023)

Table 8. Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (2018-2023) & (USD/Unit)

Table 9. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2024-2029) & (K Units)

Table 10. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Type (2024-2029)

Table 11. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2024-2029) & (US$ Million)

Table 12. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Type (2024-2029)

Table 13. Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (2024-2029) & (USD/Unit)

Table 14. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (K Units)

Table 15. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (US$ Million)

Table 16. Europe Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Type (2018-2023)

Table 17. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (US$ Million)

Table 18. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Type (2018-2023)

Table 19. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (US$ Million)

Table 20. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Type (2018-2023)

Table 21. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (US$ Million)

Table 22. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Type (2018-2023)

Table 23. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (US$ Million)

Table 24. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Company (2018-2023) & (K Units)

Table 25. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Company (2018-2023)

Table 26. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (2018-2023) & (US$ Million)

Table 27. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Company (2018-2023)

Table 28. Global Market Congestive Heart Failure (CHF) Treatment Devices Price by Company (2018-2023) & (USD/Unit)

Table 29. Global Congestive Heart Failure (CHF) Treatment Devices Top Manufacturers Manufacturing Base Distribution and Sales Area

Table 30. Global Congestive Heart Failure (CHF) Treatment Devices Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Congestive Heart Failure (CHF) Treatment Devices as of 2022)

Table 32. Date of Key Manufacturers Enter into Congestive Heart Failure (CHF) Treatment Devices Market

Table 33. Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Type

Table 34. Mergers & Acquisitions, Expansion Plans

Table 35. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029

Table 36. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2018-2023) & (K Units)

Table 37. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Region (2018-2023)

Table 38. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2018-2023) & (US$ Million)

Table 39. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Region (2018-2023)

Table 40. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 41. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2024-2029) & (K Units)

Table 42. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Region (2024-2029)

Table 43. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2024-2029) & (US$ Million)

Table 44. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Region (2024-2029)

Table 45. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)

Table 46. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 47. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (K Units)

Table 48. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Application (2018-2023)

Table 49. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (US$ Million)

Table 50. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Application (2018-2023)

Table 51. Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (2018-2023) & (USD/Unit)

Table 52. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2024-2029) & (K Units)

Table 53. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Application (2024-2029)

Table 54. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2024-2029) & (US$ Million)

Table 55. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Application (2024-2029)

Table 56. Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (2024-2029) & (USD/Unit)

Table 57. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) (K Units)

Table 58. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (US$ Million)

Table 59. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) (K Units)

Table 60. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (US$ Million)

Table 61. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) (K Units)

Table 62. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (US$ Million)

Table 63. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) (K Units)

Table 64. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (US$ Million)

Table 65. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) (K Units)

Table 66. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (US$ Million)

Table 67. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023) & (K Units)

Table 68. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Country (2018-2023)

Table 69. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023) & (US$ Million)

Table 70. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Country (2018-2023)

Table 71. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2024-2029) & (K Units)

Table 72. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Country (2024-2029)

Table 73. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2024-2029) & (US$ Million)

Table 74. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Country (2024-2029)

Table 75. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023) & (K Units)

Table 76. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Country (2018-2023)

Table 77. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023) & (US$ Million)

Table 78. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Country (2018-2023)

Table 79. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2024-2029) & (K Units)

Table 80. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Country (2024-2029)

Table 81. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2024-2029) & (US$ Million)

Table 82. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Country (2024-2029)

Table 83. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2018-2023) & (K Units)

Table 84. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Region (2018-2023)

Table 85. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2018-2023) & (US$ Million)

Table 86. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Region (2018-2023)

Table 87. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2024-2029) & (K Units)

Table 88. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Region (2024-2029)

Table 89. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2024-2029) & (US$ Million)

Table 90. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Region (2024-2029)

Table 91. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023) & (K Units)

Table 92. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Country (2018-2023)

Table 93. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023) & (US$ Million)

Table 94. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Country (2018-2023)

Table 95. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2024-2029) & (K Units)

Table 96. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Country (2024-2029)

Table 97. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2024-2029) & (US$ Million)

Table 98. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Country (2024-2029)

Table 99. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023) & (K Units)

Table 100. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Country (2018-2023)

Table 101. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023) & (US$ Million)

Table 102. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Country (2018-2023)

Table 103. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2024-2029) & (K Units)

Table 104. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Country (2024-2029)

Table 105. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2024-2029) & (US$ Million)

Table 106. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Country (2024-2029)

Table 107. Abiomed Company Information

Table 108. Abiomed Introduction and Business Overview

Table 109. Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 110. Abiomed Congestive Heart Failure (CHF) Treatment Devices Product

Table 111. Abiomed Recent Development

Table 112. Berlin Heart GmbH Company Information

Table 113. Berlin Heart GmbH Introduction and Business Overview

Table 114. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 115. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product

Table 116. Berlin Heart GmbH Recent Development

Table 117. Biotronik SE & Co. KG Company Information

Table 118. Biotronik SE & Co. KG Introduction and Business Overview

Table 119. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 120. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product

Table 121. Biotronik SE & Co. KG Recent Development

Table 122. Boston Scientific Corporation Company Information

Table 123. Boston Scientific Corporation Introduction and Business Overview

Table 124. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 125. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product

Table 126. Boston Scientific Corporation Recent Development

Table 127. HeartWare International Company Information

Table 128. HeartWare International Introduction and Business Overview

Table 129. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 130. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product

Table 131. HeartWare International Recent Development

Table 132. Jarvik Heart Company Information

Table 133. Jarvik Heart Introduction and Business Overview

Table 134. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 135. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product

Table 136. Jarvik Heart Recent Development

Table 137. LivaNova PLC Company Information

Table 138. LivaNova PLC Introduction and Business Overview

Table 139. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 140. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product

Table 141. LivaNova PLC Recent Development

Table 142. Medtronic Company Information

Table 143. Medtronic Introduction and Business Overview

Table 144. Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 145. Medtronic Congestive Heart Failure (CHF) Treatment Devices Product

Table 146. Medtronic Recent Development

Table 147. ReliantHeart Company Information

Table 148. ReliantHeart Introduction and Business Overview

Table 149. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 150. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product

Table 151. ReliantHeart Recent Development

Table 152. Abbott Company Information

Table 153. Abbott Introduction and Business Overview

Table 154. Abbott Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 155. Abbott Congestive Heart Failure (CHF) Treatment Devices Product

Table 156. Abbott Recent Development

Table 157. Key Raw Materials Lists

Table 158. Raw Materials Key Suppliers Lists

Table 159. Congestive Heart Failure (CHF) Treatment Devices Market Trends

Table 160. Congestive Heart Failure (CHF) Treatment Devices Market Drivers

Table 161. Congestive Heart Failure (CHF) Treatment Devices Market Challenges

Table 162. Congestive Heart Failure (CHF) Treatment Devices Market Restraints

Table 163. Congestive Heart Failure (CHF) Treatment Devices Distributors List

Table 164. Congestive Heart Failure (CHF) Treatment Devices Downstream Customers

Table 165. Research Programs/Design for This Report

Table 166. Key Data Information from Secondary Sources

Table 167. Key Data Information from Primary Sources

List of Figures

Figure 1. Congestive Heart Failure (CHF) Treatment Devices Product Picture

Figure 2. Global Congestive Heart Failure (CHF) Treatment Devices Market Size, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Status and Outlook (2018-2029) & (US$ Million)

Figure 4. Global Congestive Heart Failure (CHF) Treatment Devices Sales Status and Outlook (2018-2029) & (K Units)

Figure 5. Product Picture of Cardiac Resynchronization Therapy (CRT)

Figure 6. Global Cardiac Resynchronization Therapy (CRT) Sales YoY Growth (2018-2029) & (K Units)

Figure 7. Product Picture of Implantable Cardioverter Defibrillators (ICDs)

Figure 8. Global Implantable Cardioverter Defibrillators (ICDs) Sales YoY Growth (2018-2029) & (K Units)

Figure 9. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2029) & (US$ Million)

Figure 10. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type in 2022 & 2029

Figure 11. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Type in 2022

Figure 12. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Type in 2022

Figure 13. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Type in 2022

Figure 14. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Type in 2022

Figure 15. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Type in 2022

Figure 16. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Type in 2022

Figure 17. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Type in 2022

Figure 18. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Type in 2022

Figure 19. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Type in 2022

Figure 20. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Type in 2022

Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Congestive Heart Failure (CHF) Treatment Devices Sales in 2022

Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Congestive Heart Failure (CHF) Treatment Devices Revenue in 2022

Figure 23. Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 24. Product Picture of Left Ventricular Assist Device (LVAD)

Figure 25. Global Left Ventricular Assist Device (LVAD) Sales YoY Growth (2018-2029) & (K Units)

Figure 26. Product Picture of Right Ventricular Assist Device (RVAD)

Figure 27. Global Right Ventricular Assist Device (RVAD) Sales YoY Growth (2018-2029) & (K Units)

Figure 28. Product Picture of Biventricular Assist Device (BIVAD)

Figure 29. Global Biventricular Assist Device (BIVAD) Sales YoY Growth (2018-2029) & (K Units)

Figure 30. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2029) & (US$ Million)

Figure 31. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application in 2022 & 2029

Figure 32. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Application in 2022

Figure 33. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Application in 2022

Figure 34. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Application in 2022

Figure 35. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Application in 2022

Figure 36. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Application in 2022

Figure 37. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Application in 2022

Figure 38. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Application in 2022

Figure 39. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Application in 2022

Figure 40. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Application in 2022

Figure 41. Key Raw Materials Price

Figure 42. Congestive Heart Failure (CHF) Treatment Devices Manufacturing Cost Structure

Figure 43. Congestive Heart Failure (CHF) Treatment Devices Industrial Chain Analysis

Figure 44. Channels of Distribution

Figure 45. Distributors Profiles

Figure 46. Bottom-up and Top-down Approaches for This Report

Figure 47. Data Triangulation

Figure 48. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions